about
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Usin...
Read More
1.24
0.03
(2.48%)
12,844
XNAS Volume
XNAS 14 Jul, 2025 5:30 PM (EDT)
Not Eligible
Mid Valuation
Technically Neutral
Synlogic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..